R&D

News

MSD's $349m alliance with Variational, and other AI news

MSD signs $345m alliance with Variational AI, plus updates on AI in drug discovery projects from Bio Protocol, Dalton Tx, Virginia Tech, and Insilico.

News

Silhouette contemplates time clock, lightbulbs of thought on sepia background

UK specialists call for more testing on psychedelics

UK psychiatrists have called for a relaxation of restrictive rules on testing psychedelics, which are holding back research and clinical use.

News

As Trump visits UK, GSK pledges $30bn in US investment

GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.

News

Fresh blow to UK life sciences as MSD abandons £1bn project

In a blow to UK life science ambitions, MSD has scrapped a £1bn expansion of its operations in the country, saying it does not value innovation.

News

Lilly offers AI discovery models to biotech partners

Eli Lilly is offering AI-powered drug discovery models developed at a cost of around $1 billion to biotech companies for free.

News

Gilead, Amgen kick off facility investments in US

This week saw both Gilead Sciences and Amgen start to fulfil pledges to step up capital investments in new US facilities.

MSD's $349m alliance with Variational, and other AI news

UK specialists call for more testing on psychedelics

As Trump visits UK, GSK pledges $30bn in US investment

Fresh blow to UK life sciences as MSD abandons £1bn project

Lilly offers AI discovery models to biotech partners

Gilead, Amgen kick off facility investments in US

FDA points to liver injury with Amgen's Tavneos

Using AI-driven synthetic personas to take your insights fur...

R&D

Editor's Picks